Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.
Also called NCT01850901
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 139 participants
- Sponsor
- Registry
-
NCT01850901
-
- Other papers using this trial's data
- Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01850901. Randomized; no masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2016-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
- Acronym
- SYMPATHY
- Condition
- Hypertension
- Condition
- Chronic Kidney Disease
- Intervention (Procedure)
- Renal sympathetic denervation
- Lead sponsor
- UMC Utrecht
- Collaborator
- ZonMw: The Netherlands Organisation for Health Research and Development
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct01850901- Content hash
f7ce3d49f5b6a86c760bf1b9b7e3de12394e3134cb09f83d9afa551de2df9568